Therapeutic strategies for aging include mTOR inhibitors, antioxidants, anti-aging therapies, and calorie restriction, whereas IPF-specific treatments focus on antifibrotic agents and telomerase activation (Cătană et al., 2018). Here, MTOR is linked to idiopathic pulmonary fibrosis.